Cargando…
Cost-effectiveness strategies in OSAS management: a short review
Obstructive sleep apnoea (OSAS) is an underdiagnosed chronic disease with a high prevalence in adults. It is becoming a significant social problem, since it is associated with a worsening in quality of life and increase in mortality. The cost-effectiveness ratio of diagnostic and therapeutic managem...
Autores principales: | Toraldo, D.M., Passali, D., Sanna, A., De Nuccio, F., Conte, L., De Benedetto, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SRL
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782420/ https://www.ncbi.nlm.nih.gov/pubmed/28663598 http://dx.doi.org/10.14639/0392-100X-1520 |
Ejemplares similares
-
OSAS and metabolic diseases: Round Table, 99(th) SIO National Congress, Bari 2012
por: PASSÀLI, D., et al.
Publicado: (2014) -
Obstructive sleep apnoea syndrome:
a new paradigm by chronic nocturnal intermittent
hypoxia and sleep disruption
por: TORALDO, D.M., et al.
Publicado: (2015) -
The Relationship between Disturbed Sleep, OSAS, and Metabolic Diseases
por: Tatti, Patrizio, et al.
Publicado: (2019) -
A review of the “OMICS” for management of patients with obstructive sleep apnoea
por: Conte, Luana, et al.
Publicado: (2020) -
OSAS: its burden increases, not enough the awareness
por: Sanna, Antonio, et al.
Publicado: (2018)